HBM Healthcare Investments AG (ETR:CH001262)

PRESS RELEASE

published on 07/01/2026 at 17:50, 4 months 5 days ago

HBM Healthcare Investments delivers strong quarterly performance, expects profit of CHF 238 million
HBM Healthcare Investments reports strong quarterly performance with an expected profit of CHF 238 million, driven by value growth in portfolio companies and M&A activities in the biotechnology sector

HBM Healthcare Investments Biotechnology Sector Portfolio Companies Quarterly Performance CHF 238 Million
PRESS RELEASE

published on 07/01/2026 at 17:47, 4 months 5 days ago

Key Figures 30.06.2026
HBM Healthcare Investments AG reports key financial figures for June 30, 2026, showing positive performance in CHF. For more details visit hbmhealthcare.com

Performance Financial Figures HBM Healthcare Investments AG Key Figures CHF
BRIEF

published on 06/16/2026 at 17:51, 4 months 20 days ago

HBM Healthcare Investments Reports June 2026 Key Figures

Financial Performance Net Asset Value Key Figures Share Price HBM Healthcare
PRESS RELEASE

published on 06/16/2026 at 17:46, 4 months 20 days ago

Key Figures 15.06.2026
HBM Healthcare Investments AG reports key figures for June 15, 2026, showing performance growth in CHF. Monthly and year-to-date results included

Performance HBM Healthcare Investments AG Key Figures CHF June 15 2026
BRIEF

published on 06/15/2026 at 17:18, 4 months 21 days ago

HBM Healthcare Investments' Shareholders Approve Key Proposals

Shareholders' Meeting Capital Reduction Dividend Approval Board Re-elections HBM Healthcare
PRESS RELEASE

published on 06/15/2026 at 17:13, 4 months 21 days ago

Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
HBM Healthcare Investments AG Shareholders’ Meeting approves all Board proposals including re-election of Chair and board members, dividend payment, and share capital reduction

Board Of Directors Dividend Payment Shareholders' Meeting HBM Healthcare Investments AG Share Capital Reduction
BRIEF

published on 06/11/2026 at 07:05, 4 months 26 days ago

HBM Healthcare Investments Gains from Parabilis Medicines' Successful IPO

Stock Market Biopharmaceuticals HBM Healthcare Investment Gain Parabilis IPO
PRESS RELEASE

published on 06/11/2026 at 07:00, 4 months 26 days ago

HBM Healthcare Investments benefits from successful IPO of Parabilis Medicines
HBM Healthcare Investments benefits from successful IPO of Parabilis Medicines, a clinical-stage biopharmaceutical company focused on developing cancer therapies. Parabilis IPO marks significant milestone in biotechnology sector

HBM Healthcare Investments IPO Biopharmaceutical Cancer Therapies Parabilis Medicines
BRIEF

published on 06/01/2026 at 17:51, 5 months 5 days ago

HBM Healthcare Investments Reports Steady Performance

Financial Performance Net Asset Value HBM Healthcare Investments Swiss Market Share Price Growth
PRESS RELEASE

published on 06/01/2026 at 17:46, 5 months 5 days ago

Key Figures 31.05.2026
HBM Healthcare Investments AG reports key figures for May 2026, showing NAV at 287.92 CHF with a 2.5% CYTD performance. Share price at 238.00 CHF with 5.1% performance CYTD

Financial Performance HBM Healthcare Investments AG Key Figures CHF May 2026

Published on 11/06/2026 at 22:15, 17 hours 2 minutes ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 2 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 2 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 2 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 1 day 5 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

Published on 11/07/2026 at 13:35, 1 hour 42 minutes ago

Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 19 hours 2 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 20 hours 1 minute ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 20 hours 17 minutes ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 20 hours 44 minutes ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond

View all EQS

Published on 11/06/2026 at 18:00, 21 hours 17 minutes ago

ICADE - PR - S&P credit rating
Published on 11/06/2026 at 18:00, 21 hours 17 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 21 hours 22 minutes ago

Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 21 hours 42 minutes ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
Published on 11/06/2026 at 11:05, 1 day 4 hours ago

voting rights

View all LES ECHOS COMFI WIRE

News